{"result": "(\"entity\"<|>GORDON AL<|>PERSON<|>Gordon AL is a researcher who has contributed to the understanding of physical frailty and its implications in medicine.)\n##\n(\"entity\"<|>MASUD T<|>PERSON<|>Masud T is a researcher involved in defining and shaping frailty medicine.)\n##\n(\"entity\"<|>GLADMAN JR<|>PERSON<|>Gladman JR is a researcher who has worked on the definition and implications of physical frailty.)\n##\n(\"entity\"<|>J GERONTOL A BIOL SCI MED SCI<|>ORGANIZATION<|>Journal of Gerontology: Series A, Biological Sciences and Medical Sciences publishes research related to aging and frailty.)\n##\n(\"entity\"<|>AGE AGEING<|>ORGANIZATION<|>Age and Ageing is a journal that focuses on the health and care of older people, including frailty.)\n##\n(\"entity\"<|>J AM GERIATR SOC<|>ORGANIZATION<|>Journal of the American Geriatrics Society publishes research on geriatrics, including frailty assessments.)\n##\n(\"entity\"<|>GERIATR GERONTOL INT<|>ORGANIZATION<|>Geriatrics & Gerontology International is a journal that covers research on geriatric medicine and frailty.)\n##\n(\"entity\"<|>CURR PHARM DES<|>ORGANIZATION<|>Current Pharmaceutical Design is a journal that discusses pharmaceutical interventions for frailty and sarcopenia.)\n##\n(\"entity\"<|>CMAJ<|>ORGANIZATION<|>Canadian Medical Association Journal publishes research on various medical topics, including frailty in elderly people.)\n##\n(\"entity\"<|>RETICEF<|>ORGANIZATION<|>RETICEF is a research initiative aimed at stimulating Spanish research on aging and frailty.)\n##\n(\"entity\"<|>SHARE-FI<|>ORGANIZATION<|>The Frailty Instrument for primary care of the Survey of Health, Ageing and Retirement in Europe (SHARE-FI) is a tool for assessing frailty.)\n##\n(\"entity\"<|>MANUEL ANTON JIMENEZ<|>PERSON<|>Dr. Manuel Antón Jiménez is a researcher focusing on cognitive frailty and nutrition.)\n##\n(\"relationship\"<|>GORDON AL<|>AGE AGEING<|>Gordon AL has published research in Age and Ageing regarding physical frailty<|>7)\n##\n(\"relationship\"<|>MASUD T<|>AGE AGEING<|>Masud T has contributed to articles in Age and Ageing related to frailty medicine<|>7)\n##\n(\"relationship\"<|>GLADMAN JR<|>AGE AGEING<|>Gladman JR has worked on defining frailty in the context of research published in Age and Ageing<|>7)\n##\n(\"relationship\"<|>GORDON AL<|>J GERONTOL A BIOL SCI MED SCI<|>Gordon AL has published research in the Journal of Gerontology regarding frailty<|>7)\n##\n(\"relationship\"<|>MASUD T<|>J GERONTOL A BIOL SCI MED SCI<|>Masud T has contributed to the Journal of Gerontology on frailty medicine<|>7)\n##\n(\"relationship\"<|>GLADMAN JR<|>J GERONTOL A BIOL SCI MED SCI<|>Gladman JR has published work in the Journal of Gerontology related to frailty<|>7)\n##\n(\"relationship\"<|>MANUEL ANTON JIMENEZ<|>RETICEF<|>Dr. Manuel Antón Jiménez is involved in RETICEF, focusing on aging and frailty research<|>6)\n##\n(\"relationship\"<|>MANUEL ANTON JIMENEZ<|>GERIATR GERONTOL INT<|>Dr. Manuel Antón Jiménez has published research in Geriatrics & Gerontology International<|>6)\n##\n(\"relationship\"<|>MANUEL ANTON JIMENEZ<|>CURR PHARM DES<|>Dr. Manuel Antón Jiménez has contributed to Current Pharmaceutical Design regarding frailty<|>6)\n<|COMPLETE|>", "input": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: J Gerontol A Biol Sci Med Sci 2001; 56:M146-56.\n              Gordon AL, Masud T, Gladman JR. Now that we have a definition for physical frailty, what\n              shape should frailty medicine take? Age Ageing 2014; 43:8-9.\n---\nJones DM, Song X, RockwoodK. Operationalizing a frailty index from a standardized com-\nprehensive geriatric assessment. J Am Geriatr Soc 2004; 52:1.929-33.\nKim H, Higgins PA, Canaday DH, Burant CJ, Hornick TR. Frailty assessment in the geriatric\noutpatient clinic. Geriatr Gerontol Int 2014; 14:78-83.\nLaosa O, Alonso C, Castro M, Rodríguez-Manas L. Pharmaceutical Interventions For Frailty\nAnd Sarcopenia. Curr Pharm Des 2013.\nMorley JE, Vellas B, Van Kan GA, et al. Frailty consensus: a call to action. J Am Med Dir Assoc\n2013; 14:392-7.\nMorley JE, Von Haehling S, Anker SD, Vellas B. From sarcopenia to frailty: a road less\ntraveled. J Cachexia Sarcopenia Muscle 2014; 5:5-8.\nOtero A, Castell MV, De Hoyos MC. Frailty screening in primary care. Rev Esp Geriatr y\nGerontol 2011; 46:239-40.\nRizzoli R, Reginster JY, Arnal JF, et al. Quality of life in sarcopenia and frailty. Calcif Tissue int\n2013; 93:101-20.\nRockwood K, Fox RA, Stolee P, Robertson D, Beattie BL. Frailty in elderly people: an evolving\nconcept. CMAJ 1994; 150:489-95.\nRockwood K, Howlett SE, MacKnight C, et al. Prevalence, attributes, and outcomes of fit-\nness and frailty in community-dwelling older adults: report from the Canadian study of\nhealth and aging. J Gerontol A Biol Sci Med Sci 2004; 59:1.310-7.\nRockwood K, Hubbard R. Frailty and the geriatrician. Age Ageing 2004; 33:429-30.\nRockwood K, Song X, MacKnight C, et al. A global clinical measure of fitness and frailty in\nelderly people. CMAJ 2005; 173:489-95.\nRodríguez Manas L. RETICEF: an opportunity to stimulate Spanish research on ageing and\nfrailty. Revista Esp Geriatr Gerontol 2008; 43:68-70.\nRodriguez-Manas L, Feart C, Mann G, et al. Searching for an operational definition of frailty:\na Delphi method based consensus statement: the frailty operative definition-consensus con-\nference project. J Gerontol A Biol Sci Med Sci 2013; 68:62-7.\nRomero Ortuno R. The Frailty Instrument for primary care of the Survey of Health, Ageing\nand Retirement in Europe (SHARE-FI): results of the Spanish sample. Rev Esp Geriatr Geron-\ntol 2011; 46:243-9.\nRomero Ortuno R, Formiga F. Fitness or frailty? Does age matter? New horizons in geriatrics.            29\nRev Esp Geriatr Gerontol 2013; 48:207-8.\nRomero Rizos L, Abizanda Soler P. Frailty as a predictor of adverse events in epidemiological\nstudies: literature review. Rev Esp Geriatr Gerontol 2013; 48:285-9.\nVerghese J, Holtzer R, Lipton RB, Wang C. High-sensitivity C-reactive protein and mobility\ndisability in older adults. Age Ageing 2012; 41:541-5.\nXue QL. The frailty syndrome: definition and natural history. Clin Geriatric Med 2011; 27:1-15.\n---\nNO_CONTENT_HERE\n---\n                 Fragilidad cognitiva\n                 y nutriciónDr. Manuel Antón Jiménez\n\n\n\n– INTRODUCCIÓN\nAunque el concepto de fragilidad está fuertemente arraigado entre los profesionales\nque tratan a nuestros ancianos, la fragilidad cognitiva es todavía un concepto extrapo-\nlado a las funciones atribuidas a la cognición, que significan también una vulnerabili-\ndad especial al desarrollo de demencia establecida, por lo que podemos asimilarlo en\nla práctica a la fase preclínica o fase prodrómica que Petersen incluyó en el concepto\nde deterioro cognitivo leve. Aunque la nutrición y los micronutrientes han demostra-\ndo suficientemente su efecto beneficioso en las etapas iniciales de la vida, existen con-\ntroversias en relación a lo que determinada dieta o algunos micronutrientes pueden\naportar para impedir el paso desde fragilidad cognitiva hacia demencia establecida.\nLa malnutrición está asociada al deterioro cognitivo o pérdida funcional, pero tambien\nse sabe que un estado nutricional inad\n######################\nOutput:", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": null}